Skip to main content
Equibles

OGI · Organigram Global Inc. · Metrics

Track OGI — free

Use OGI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OGI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.88 -0.05 (-5.72%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$123.61M
Shares
141.01M
Volume · Nov 6 1.13M Avg daily vol (3M) 939.93K

OGI metrics

51 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.88
Market cap
$123.61M

Price action

23 metrics
Price change (1W)
-6.1%
Price change (30D)
-7.8%
Price change (3M)
-11.5%
Price change (6M)
-35.5%
Price change (YTD)
-47.8%
Price change (1Y)
-40.8%
Trailing year
Price change (5Y)
—
52-week high
$2.11
52-week low
$0.87
Change from 52-week high
-58.5%
Change from 52-week low
+0.6%
Annualized volatility
57.6%
Annualized volatility (3M)
53.6%
Implied volatility (30D)
75.4%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.1
RSI (14D)
36.6
Price vs SMA 50
-13.8%
Price vs SMA 200
-25.9%
Avg volume (3M)
939,932
Relative volume
1.2
Average dollar volume
$1.07M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
141.01M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.5
reciprocal yield 202.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
34.8%
Operating margin
-5.9%
Trailing 12 months
Net margin
-9.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.82

Growth

11 metrics
Revenue growth YoY
+62.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
+21.1%
Revenue CAGR (5Y)
+24.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-7.1%
Return on assets
-4.4%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$60.02M
Total assets
$403.68M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
69
13F filer change QoQ
-6
Institutional ownership
5.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.5%
Holder tenure
4.8
Price vs estimated holder cost
-23.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.4%

Short interest

3 metrics
Short interest
3.4%
Latest settlement · 11.7 days to cover
Days to cover
11.7d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1620737 CUSIP 68617J100 13F (30d) 32 filings 32 filers Visit website Investor relations